Menu
Not yet recruiting NCT04901104

Long-term Prognosis of Patients With Sepsis After Immunotherapy

— Observational Long-term Effects of Thymosin Alpha 1 Treatment

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Thymosin Alpha1.
Who it may be relevant to
Registry conditions: Long-term Effects of Thymosin Alpha 1 Treatment. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Long-term Prognosis After Thymosin Alpha 1 Treatment in Patients With Sepsis: A Multicenter Cohort Study

Overview

Current clinical studies of thymosin α1 for sepsis have focused on short-term outcomes (28-day or 90-day mortality), and lack of clinical data on long-term outcomes (3 year mortality) of patients with sepsis after immunotherapy. Based on the preliminary clinical study (NCT02867267), this study will conduct long-term follow-up for sepsis patients to provide data support for the long-term prognosis of immunotherapy.

Interventions

  • Drug Thymosin Alpha1
    Drug interventions have been done in previous clinical studies

Primary outcome measures

  • three years mortality [Time frame: 3 years]
Secondary outcome measures (4)
  • Recurrence rate of sepsis [Time frame: 5 years]
  • one year mortality [Time frame: 1 year]
  • Five years mortality [Time frame: 5 years]
  • short form 36 questionnaire [Time frame: 1 year]

Eligibility criteria

Inclusion criteria

  • Sepsis patients in the TESTS study Patients who discharged from hospital after recovery

Exclusion criteria

  • None

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT04901104 · Long-term prognosis in sepsis

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗